Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity
Authors:
Preprint
Abstract
To dissect variant-function relationships in the KRAS oncoprotein, we performed deep mutational scanning (DMS) screens for both wild-type and KRAS G12D mutant alleles. We defined the spectrum of oncogenic potential for nearly all possible KRAS variants, identifying several novel transforming alleles and elucidating a model to describe the frequency of KRAS mutations in human cancer as a function of transforming potential, mutational probability, and tissue-specific mutational signatures. Biochemical and structural analyses of variants identified in a KRAS G12D second-site suppressor DMS screen revealed that attenuation of oncogenic KRAS can be mediated by protein instability and conformational rigidity, resulting in reduced binding affinity to effector proteins, such as RAF and PI3-kinases, or reduced SOS-mediated nucleotide exchange activity. These studies define the landscape of single amino acid alterations that modulate the function of KRAS, providing a resource for the clinical interpretation of KRAS variants and elucidating mechanisms of oncogenic KRAS inactivation for therapeutic exploitation.Keywords
This publication has 97 references indexed in Scilit:
- Production of Farnesylated and Methylated Proteins in an Engineered Insect Cell System2019
- KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent MannerBiophysical Journal, 2019
- Optimizing Expression and Solubility of Proteins in E. coli Using Modified Media and Induction Parameters2017
- Association Between Specific Mutations inKRASCodon 12 and Colorectal Liver MetastasisJAMA Surgery, 2015
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- Characterization of a novel KRAS mutation identified in Noonan syndromeAmerican Journal of Medical Genetics Part A, 2012
- Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disordersHuman Mutation, 2010
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- A Novel Activating Mutation of the K-ras Gene in Human Primary Colon AdenocarcinomaBiochemical and Biophysical Research Communications, 2000